| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02125835 |
| P698 | PubMed publication ID | 3154310 |
| P2093 | author name string | W W Parmley | |
| J Garrett | |||
| T Rashid | |||
| R E Sievers | |||
| S Blumlein | |||
| P2860 | cites work | Pathology of atherosclerosis | Q28243600 |
| Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. A possible mechanism for its antiatherogenic effect | Q34627457 | ||
| OBSERVATIONS CONCERNING THE EVOLUTION OF ATHEROSCLEROSIS IN THE RABBIT AFTER CESSATION OF CHOLESTEROL FEEDING | Q35943614 | ||
| Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine | Q37005715 | ||
| Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis | Q37021840 | ||
| Modification of experimental atherosclerosis by calcium-channel blockers | Q39814235 | ||
| Atherosclerosis, calcium, and calcium antagonists | Q39824377 | ||
| Comparative effects of cetaben (PHB) and dichlormethylene diphosphonate (Cl2MDP) on the development of atherosclerosis in the cynomolgus monkey | Q39868402 | ||
| “Calcium-antagonists” and antherosclerosis — basic studies and therapeutic implications | Q40146650 | ||
| Experimental models of atherosclerosis regression | Q40208739 | ||
| The effect of agents interfering with soft tissue calcification and cell proliferation on calcific fibrous-fatty plaques in rabbits | Q41375246 | ||
| Regression of atheroma in the rabbit | Q43842318 | ||
| Suppression of calcific fibrous-fatty plaque formation in rabbits by agents not affecting elevated serum cholesterol levels. The effect of thiophene compounds | Q43937258 | ||
| Verapamil suppresses atherosclerosis in cholesterol-fed rabbits | Q46576650 | ||
| The effects of propranolol on cholesterol-induced atheromatous lesions | Q69591389 | ||
| Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits | Q70104071 | ||
| Effects of propranolol on atherogenesis in the cholesterol-fed rabbit | Q70106620 | ||
| Prevention of vascular lesions by chondroitin sulfate a in the coronary artery and aorta of rats induced by a hypervitaminosis D, cholesterol-containing diet | Q70472783 | ||
| Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit | Q70635888 | ||
| Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids | Q71568749 | ||
| Effects of agents altering vascular calcium in experimental atherosclerosis | Q71583721 | ||
| Experimental atherosclerosis in rabbits with special reference to reversal | Q71657771 | ||
| Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits | Q71801769 | ||
| Production of advanced cholesterol atherosclerosis in the rabbit | Q78825676 | ||
| P433 | issue | 1 | |
| P921 | main subject | verapamil | Q410291 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 65-69 | |
| P577 | publication date | 1987-01-01 | |
| P1433 | published in | Cardiovascular Drugs and Therapy | Q2473050 |
| P1476 | title | Verapamil and diet halt progression of atherosclerosis in cholesterol fed rabbits | |
| P478 | volume | 1 |
| Q67269597 | Calcium antagonists--future uses |
| Q39612911 | Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials |
| Q39612740 | Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications |
| Q58863703 | Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals |
| Q35166872 | Can the Coronary Atherosclerotic Process Be Influenced by Calcium Antagonists? |
| Q33697575 | Carotid artery wall alterations as intermediate end points |
| Q35729368 | Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators |
| Q40387984 | Effect of verapamil on atherosclerosis |
| Q35874024 | Effect of verapamil on intimal thickening and vascular reactivity in the collared carotid artery of the rabbit |
| Q42505831 | HMG-CoA reductase inhibitor stabilizes rabbit atheroma by increasing basal NO and decreasing superoxide |
| Q37807090 | Modification of experimental and clinical atherosclerosis by dietary fish oil. |
| Q36960568 | Nifedipine gastrointestinal therapeutic system: an overview of its antiatherosclerotic effects |
| Q44092703 | Quantitative analysis of antiatherosclerotic effect of nifedipine in cholesterol-fed rabbits |
| Q70244057 | Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy) |
| Q35898768 | The antiatherogenic effects of antihypertensive drugs: experimental and clinical evidence. |
Search more.